Profile

Alain Bernard is currently the Chief Technology Officer at VectivBio Holding AG since 2019.
Prior to this, he worked as the Head-Global Biotech Process Development at R-Pharm JSC from 2017 to 2019, Vice President-Biopharmaceutical Process Sciences at UCB SA from 2006 to 2016, and Director-Biotech Process Development at Merck Serono SA from 2002 to 2006.
Dr. Bernard holds a doctorate degree from the Massachusetts Institute of Technology.

Former positions of Alain Bernard

CompaniesPositionEnd
Corporate Officer/Principal 30/06/2019
UCB Corporate Officer/Principal 31/12/2015
Corporate Officer/Principal 31/10/2006
VECTIVBIO HOLDING AG Chief Tech/Sci/R&D Officer -
See the detail of Alain Bernard's experience

Training of Alain Bernard

Massachusetts Institute of Technology Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alain Bernard's experience

Connections

61

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
UCB

Health Technology

Private companies3

Health Technology

Health Technology

Health Technology

See company connections